|1.||Verdouw, P D: 1 article (07/2001)|
|2.||Lamers, J M: 1 article (07/2001)|
|3.||Slager, C J: 1 article (07/2001)|
|4.||Krams, R: 1 article (07/2001)|
|5.||Trines, S A: 1 article (07/2001)|
|6.||Onderwater, T A: 1 article (07/2001)|
|7.||Korbmacher, B: 1 article (07/2000)|
|8.||Sunderdiek, U: 1 article (07/2000)|
|9.||Schipke, J D: 1 article (07/2000)|
|10.||Gams, E: 1 article (07/2000)|
|1.||Myocardial Stunning (Stunned Myocardium)
12/10/1999 - "In conclusion, both doses of EMD 60263 improved systolic as well as diastolic function of stunned myocardium. "
12/10/1999 - "EMD 60264 did not affect systolic shortening but decreased mean rate of half end-diastolic lengthening in normal myocardium to 61+/-8% and in stunned myocardium to 16+/-5% of baseline. "
05/03/1996 - "The results indicate that the positive inotropic action of [+]EMD 60263 observed in the in situ porcine model of stunned myocardium may be primarily due to myofilament sensitization to Ca2+, and that this compound may have a similar action on diseased human myocardium."
11/01/1997 - "Previously we showed in an in situ porcine model that the thiadiazinone derivative [+]EMD 60263, a Ca2+ sensitizer without phosphodiesterase III inhibitory properties, increased contractility more profoundly in stunned than in non-stunned myocardium. "
12/10/1999 - "This is the first in vivo study of the effects of the thiadiazinone derivative EMD 60263 ((+)-5-(l-(alpha-ethylimino-3, 4-dimethoxybenzyl)-1,2,3,4-tetrahydroquinoline-6-yl)-6-methyl-3, 6-dihydro-2H-1,3,4-thiadiazine-2-on), a Ca(2+)-sensitizing agent with negligible phosphodiesterase III inhibitory activity, on diastolic function of regionally stunned myocardium. "
07/01/2001 - "After stunning (two times 10-min ischemia followed by 30-min reperfusion), measurements were repeated following infusion of saline (n=8) or EMD 60263 (1.5 mg.kg(-1) i.v., n=10). "
07/01/2000 - "The effects of a novel Ca(2+)-sensitizer (EMD 60263, 10 microM, group 1) were compared with a phosphodiesterase (PDE) III-inhibitor (enoximon, 20 microM, group 2) on 14 isolated, blood-perfused rabbit hearts during reperfusion after a global ischemia of 20 min. Ventricular function, the pressure-volume area (PVA, a measure of total mechanical work), and total myocardial oxygen consumption (MVO(2)) were assessed. "
08/01/1994 - "Because EMD 60263 decreased heart rate from 106 +/- 4 to 76 +/- 3 beats per minute (P < .05) in the animals with stunned myocardium, we performed five experiments with the specific negative chronotropic compound zatebradine (UL-FS 49, 0.1 to 0.5 mg/kg) to rule out bradycardia as a factor contributing to the effects of EMD 60263. "
|1.||Type 3 Cyclic Nucleotide Phosphodiesterases